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Summary
A system is reported for the recombinant expression
of individual ketoreductase (KR) domains from modu-
lar polyketide synthases (PKSs) and scrutiny of their
intrinsic specificity and stereospecificity toward sur-
rogate diketide substrates. The eryKR1 and the tylKR1
domains, derived from the first extension module of
the erythromycin PKS and the tylosin PKS, respec-
tively, both catalyzed reduction of (2R, S)-2-methyl-3-
oxopentanoic acid N-acetylcysteamine thioester, with
complete stereoselectivity and stereospecificity, even
though the substrate is not tethered to an acyl carrier
protein or an intact PKS multienzyme. In contrast, and
to varying degrees, the isolated enzymes eryKR2,
eryKR5, and eryKR6 exercised poorer control over
substrate selection and the stereochemical course of
ketoreduction. These data, together with modeling of
diketide binding to KR1 and KR2, demonstrate the fine
energetic balance between alternative modes of pre-
sentation of ketoacylthioester substrates to KR active
sites.
Introduction
Modular type I polyketide synthases (PKSs), for example
the 6-deoxyerythronolide B synthase (DEBS) responsi-
ble for synthesis of the aglycone core of the macrolide
antibiotic erythromycin A, are giant, multifunctional en-
zymes that catalyze the assembly line biosynthesis of
structurally complex and clinically important polyketide
natural products [1, 2]. Polyketide chain assembly re-
sembles fatty acid biosynthesis in that acyl-CoA starter
units and extender units are condensed together, with-
out the intermediates being released into solution. In
contrast to fatty acid biosynthesis, modular PKSs utilize
a wider variety of starter and extender units, and the
b-keto functionality created after each condensation
step is not necessarily fully reduced before the next
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3These authors contributed equally to this work.cycle of chain extension, leading to a far greater poten-
tial for chemical and stereochemical diversity in the
products. Numerous strategies have been successfully
developed to engineer modular PKSs, and also down-
stream post-PKS enzymes, to produce chemically
altered products for use in drug discovery [3–7]. In con-
trast, attempts to alter the configuration at specific ster-
eocenters have so far been hampered by our limited
understanding of the fundamental mechanisms by which
PKSs exert stereocontrol over polyketide assembly.
Each PKS extension module contains a ketosynthase
(KS) domain, which catalyzes the formation of a carbon-
carbon bond, and an acyltransferase (AT) domain, which
recruits the chain extension unit, normally from either
malonyl-CoA or methylmalonyl-CoA. The acyl carrier
protein (ACP) cooperates in the carbon-carbon bond for-
mation to form a b-ketoester and then carries the grow-
ing chain to domains involved in reductive processing of
the keto group before the next cycle of chain extension.
These reductive activities are optionally present, de-
pending on the module, and comprise: a b-ketoreduc-
tase (KR) domain, which catalyzes the reduction of the
initially formed b-ketoester to a b-hydroxyester; a de-
hydratase (DH) domain, which dehydrates the b-hydrox-
yester; and an enoyl reductase (ER) domain, which
reduces the double bond. For almost all modules, there
is a convincing correlation between the predicted con-
stituent domains and the chemical structure of the corre-
sponding chain extension unit in the growing polyketide
chain. Although noncanonical modular PKSs, in which
the AT activity is carried on a discrete protein or in which
the order of domains in the multienzyme is unusual
[8–11], have recently been described, the mechanisms
for assuring chemical and stereochemical control are
believed to remain the same.
The methyl centers at C-2 and the hydroxyl centers at
C-3 generated in many newly added chain extension
units have either an R or S configuration. As early as
1965, Celmer noted that there is a strong position-
specific structural and stereochemical homology in
families of macrolide polyketides, suggesting a genetic
origin for stereochemical control at such centers [12].
The AT domains of the erythromycin PKS DEBS have
all been shown to recruit the (2S), and not the (2R), isomer
of methylmalonyl-CoA as the extension unit [13, 14];
thus, AT domains are not thought to play a primary role
in the control of stereochemistry at methyl-branched
centers in the polyketide product. This has focused
attention on the ketosynthase (KS) and ketoreductase
(KR) domains as potentially determining the outcome
of polyketide chain extension that underlies Celmer’s
Rules.
In mechanistic terms, the chirality at the hydroxyl
group must be determined by the direction of hydride ad-
dition to the keto group (reor si face) within the active site
of the KR domain. It has recently been found to be possi-
ble to correlate motifs in the amino acid sequence of PKS
KR domains with the stereochemical outcome of the
reductions they catalyze [15, 16], suggesting that the di-
rection of KR-catalyzed reduction may be ‘‘hard-wired.’’
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1146Figure 1. The Stereochemical Outcome of
Reduction of 2-Methyl-3-Oxopentanoic Acid
NAC Thioester by Erythromycin PKS Ketore-
ductases eryKR1 and eryKR2
Analysis by HPLC shows that GST-eryKR1
produces a single product with the (2S,
3R) configuration. In contrast, GST-eryKR2
yields three products.A few examples of individual KR domains have already
been successfully swapped between modules of differ-
ent PKSs resulting in the predicted products, apparently
indicating that the stereospecificity of reduction is dic-
tated by the KR domain and is transferable ([17] and
L. Kellenberger and P.F.L., unpublished data). For exam-
ple, the KS domain in the first extension module of DEBS
is capable of catalyzing the epimerization at the methyl
center of the initially formed (2R) isomer of the keto ester
to the (2S) isomer [18], and the eryKR1 domain selects
only the (2S) isomer from the mixture. In a chimaeric dike-
tide synthase that combined KS1 with the reductive en-
zyme corresponding to module 2 [19], a diketide was
produced in vivo in which the stereochemistry was al-
tered at both C-2 and C-3; this supports the idea that
both enantiomeric keto esters are formed by KS1 and
that the eryKR2 domain selects correctly between
them. However, other evidence suggests that the true
situation is more complex and that the direction of reduc-
tion can be influenced by the nature of the substrate [20].
For example, when KS1 was engineered in place of er-
yKS5 in a triketide lactone synthase model system based
on DEBS 3, giving rise to both the (2R) and (2S) isomers of
the diketide intermediate, the KR domains (eryKR5 and
eryKR6) carried out reduction at both the re and si faces
of their substrates [20].
In vitro studies on purified enzymes have been under-
taken in an attempt to clarify some of these issues, andto uncover a structural basis for the observed stereo-
control by KR domains. Studies have been made of
the effects of mutations in eryKR6 on the rate of exten-
sion of a diketide thioester substrate by recombinant
DEBS module 6-thioesterase (TE) expressed in E. coli
[15], and to measure the kinetics of chain extension on
diketide synthases containing only DEBS module 2
[19] or DEBS module 1 [21]. Unfortunately, in such ex-
periments, only the overall kinetic behavior of a multien-
zyme in which stereocontrol is potentially exercized at
more than one step is measured. We have previously
shown that the KR activities can be specifically assayed
(as for fatty acid synthases [22, 23]) when expressed as
part of a PKS [20, 21, 24], by using (2R, S)-2-methyl-3-
oxopentanoic acid N-acetylcysteamine (NAC) thioester
(Figure 1). In these experiments, eryKR1 was found to
be both stereoselective and stereospecific, as it was
able to select the expected (2S) stereoisomer out of a ra-
cemic mixture and make the expected (2S, 3R) product.
The KR2 was less active toward the racemic substrate,
but it was still able to make the expected (2R, 3S) iso-
mer. However, when the same model substrate was re-
duced in vitro by purified DEBS 3 (which contains two
KR domains, eryKR5 and eryKR6, both producing the
same stereochemical outcomes as eryKR2 during nor-
mal chain extension), comparable amounts of all four
possible stereoisomers of the product alcohol were
reported to be obtained [20], implying a loss of
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have raised interesting (and as yet unresolved) ques-
tions as to how the (stereo)specificity of an individual
KR domain is influenced by both its context within the
PKS and the tethering of the substrate to an acyl carrier
protein.
We describe here the expression and purification of
individual KR domains of PKSs as soluble and enzymat-
ically active proteins in recombinant E. coli, in the ab-
sence of other PKS components. This advance has
allowed measurement of the kinetics and stereochemis-
try of ketoreduction of model substrates for eryKR1,
eryKR2, eryKR5, eryKR6, and tylosin KR1 (tylKR1). We
have also undertaken detailed molecular modeling
(A.B.-O. et al., submitted) of representative KR domains
and of the way in which a diketide substrate might be
accommodated in the active site. Our results reveal
that at least some isolated KR domains are intrinsically
capable of showing a very high specificity and stereo-
specificity toward the untethered surrogate substrates
used here; however, other KR domains are less discrim-
inating. The energetic differences between alternative
binding modes that lead to different chiral products
are clearly rather small.
Results and Discussion
Expression of PKS Ketoreductase Domains
Individual KR domains were expressed as glutathione-
S-transferase (GST) fusion proteins in E. coli. For
eryKR1, the fragment was designed to contain the KR
domain (170 amino acid residues) and also the ‘‘linker’’
regions flanking the KR, consisting of an N-terminal re-
gion of some 225 amino acid residues up to the preced-
ing AT domain, and a C-terminal region of some 75
amino acid residues up to the start of the ACP domain.
The N terminus was selected to coincide with a major
site for limited proteolysis of DEBS [25], and the C termi-
nus was selected to coincide with a site used in previ-
ously successful KR engineering and domain swaps
([21]; L.E. Kellenberger and P.F.L., unpublished data).
For eryKR2, eryKR5, eryKR6, and tylKR1 the respective
N and C termini of the recombinant domain were se-
lected by ClustalW sequence alignment [26] of their se-
quences with that of eryKR1. The respective nucleic
acid fragments were amplified from cloned PKS tem-
plates by using mutagenic PCR, which introduced flank-
ing BamHI and EcoRI sites and a stop codon just
upstream of the EcoRI site.
Initially, each fragment was cloned into the expres-
sion vector pGEX-4T-3 (Amersham), according to the
manufacturer’s instructions, from which the GST fusion
protein was in each case expressed in E. coli as a solu-
ble protein and was purified to homogeneity by affinity
chromatography on glutathione-agarose. Thrombin was
used to cleave eryKR1, eryKR2, eryKR5, and eryKR6
from their respective fusion proteins, and the KR1 do-
main was purified in further chromatographic steps to
apparent homogeneity. The purified eryKR1 domain be-
haved as a monomer on gel filtration (expected Mr,
54,900; observed apparent Mr, 58,800) (data not shown).
In contrast, release of the other KR domains from the re-
spective N-terminal GST fusion protein was slow, and
the use of increased concentrations of thrombin led tomultiple products of nonspecific cleavage. Therefore,
the coding regions for the KR domains were all re-
cloned, as BamHI-EcoRI fragments, into the related ex-
pression plasmid pGEX-6P-1, in which the N-terminally
fused GST is released by use of the highly specific rhi-
novirus 2C proteinase (PreScission Protease [Amer-
sham]), rather than by thrombin. After expression and
affinity purification of the fusion proteins as described
in Experimental Procedures, each KR domain was effi-
ciently released by using this proteinase and was puri-
fied to near homogeneity (>90%–95%, the balance
being a small amount of residual GST contaminant)
by subsequent ion-exchange chromatography. In each
case, the KR domain was obtained as a single protein
species of exactly the predicted molecular mass, as
judged by electrospray MS analysis (data not shown).
Kinetic Analysis of Individual KR Domains
Kinetic analysis was performed as detailed in Experi-
mental Procedures to determine the steady-state ki-
netic constants for the NADPH-linked reduction of (9R,
S)-trans-1-decalone [22], which we have previously
shown to be a useful surrogate substrate for PKS KR
domains [21]. The results are given in Table 1 and are
compared with those obtained previously for KR1
in the context of the recombinant DEBS-derived dike-
tide synthase (DKS) [21] and the triketide synthase
(DEBS1-TE [DKR2]) [21]. Assays were also conducted
with the intact GST-KR fusion proteins. The recombi-
nant KR domains were also assayed by using (2R,
S)-2-methyl-3-oxopentanoic acid N-acetylcysteamine
(NAC) thioester as substrate [21] (Table 2). All experi-
ments were carried out in triplicate.
From the results in Tables 1 and 2, it is evident that re-
combinant KR domains derived from modular PKSs are
capable of folding to enzymatically active enzymes in E.
coli. Reassuringly, the purified recombinant eryKR1 has
values for kcat and Km (for decalone or for diketide NAC
thioester) that are not dramatically different from those
found previously for the eryKR1 domain in the context
of a modular PKS [21]. Further, the presence of an
N-terminal GST domain did not alter the behavior of
Table 1. Kinetic Parameters for Reduction of (9RS)-Trans-1-
Decalone by PKS Ketoreductases
Ketoreductase kcat (s
21) Km (mM)
kcat/Km
(M21 s21)
eryKR1 (DKS) [21] 0.53 (6 0.02) 1.2 (6 0.3) 442 (6 128)
eryKR1 (DEBS1-
TEDKR2) [21]
0.44 (6 0.05) 1.10 (6 0.01) 400 (6 49)
GST-eryKR1 0.26 (6 0.01) 2.2 (6 0.2) 118 (6 15)
eryKR1 0.13 (6 0.01) 2.8 (6 0.4) 46 (6 10)
GST-eryKR2 0.16 (6 0.01) 5 (6 1) 32 (6 8)
eryKR2 0.16 (6 0.01) 5 (6 1) 32 (6 8)
GST-eryKR5 0.12 (6 0.01) 12 (6 3) 10 (6 3)
eryKR5 0.12 (6 0.01) 10 (6 3) 12 (6 4)
GST-eryKR6 0.17 (6 0.01) 3.7 (6 0.8) 46 (6 12)
eryKR6 0.28 (6 0.04) 1.5 (6 0.7) 187 (6 114)
eryKR5 + eryKR6
(DEBS 3)
0.13 (6 0.01) 2.8 (6 0.4) 46 (6 10)
GST-tylKR1 0.18 (6 0.01) 1.4 (6 0.4) 128 (6 43)
All experiments were carried out in triplicate. Data are reported as
mean 6 SEM.
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similarly good agreement between the values obtained
for eryKR1 with diketide NAC thioester substrate,
whether measured as a GST fusion protein or as a do-
main within an engineered diketide synthase (DKS) [21].
The specificity constants (kcat/Km) in Table 2 also
show that the diketide NAC thioester is a better sub-
strate for eryKR1 and tylKR1, which normally process di-
ketide substrates, than for the other KRs; this difference
is due to a substantial decrease in the rate of turnover
(kcat) by KR2, and an increase in the Km for KRs 5 and
6. In agreement with this, it has been previously shown
that the purified DEBS 1-TE multienzyme (which con-
tains both eryKR1 and eryKR2 domains) reduces the di-
ketide NAC thioester largely via the eryKR1 active site
[24]. Overall, these kinetic data serve to reassure us
that the recombinant enzymes are all active against
plausible surrogate substrates.
Stereochemistry of Ketoreduction
We next wished to determine the stereochemical out-
come of the reaction of the recombinant KR domains
with (2R, S)-2-methyl-3-oxopentanoic acid N-acetylcys-
teamine (NAC) thioester as substrate. No attempt was
made to present the enzymes with enantiomerically
pure substrate, as spontaneous racemization under
the assay conditions is expected to be rapid. Each en-
zyme is therefore presented with two alternative enan-
tiomeric substrates, each of which can in principle be
reduced from either face of the 3-keto group; thus, there
Table 2. Steady-State Kinetic Parameters for Ketoreductase-
Catalyzed Reduction of (2R, S)-2-Methyl-3-Ketopentanoic Acid,
N-Acetylcysteamine Thioester
Ketoreductase kcat (s
21) Km (mM) kcat/Km (s
21 M21)
GST-eryKR1 0.26 6 0.01 35 6 4 7 6 1
eryKR1 (DKS) [21] 0.27 6 0.01 13 6 2 22 6 4
GST-eryKR2 0.03 6 0.01 13 6 3 2 6 1
GST-eryKR5 0.05 6 0.01 116 6 28
a 0.4 6 0.2
GST-eryKR6 0.18 6 0.02 144 6 19
a 1.3 6 0.3
GST-tylKR1 0.61 6 0.04 13 6 2 47 6 10
All experiments were carried out in triplicate. Data are reported as
mean 6 SEM.
a Due to insolubility of the substrate at concentrations in excess of
150 mM, these data represent the lower limits for the Km values.are four possible stereoisomeric products. As indicated
in Figure 1, these alcohol products can be readily sepa-
rated by using chiral HPLC. The GST fusion proteins
were used for these experiments, and the reaction prod-
ucts (normally after about 10%–20% of the initial keto
substrate had been reduced), were separated and ana-
lyzed as described in Experimental Procedures. (In pre-
liminary control experiments, in which the reaction was
stopped after 2%, 10%, and 50% conversion, respec-
tively, it was confirmed that the ratio of stereoisomers
found was independent of the extent of reduction, as
expected if the concentration ratio of 2R:2S substrates
remains 1:1 throughout.) The results of these experi-
ments are summarized in Table 3, in which the percen-
tages found for the expected product (based on the
apparent specificity of the KR domain in its native con-
text) are indicated in bold type.
A striking feature of the data in Table 3 is the very
different behavior of individual KR domains toward the
diketide substrate. First, eryKR1 selects only one enan-
tiomer of the substrate and reduces it efficiently from
only one face to give the anticipated (2S, 3R) product.
Likewise, tylKR1 selects the opposite enantiomer of
the substrate and reduces it almost cleanly to the antic-
ipated (2R, 3R) product. From these results alone, it is
evident that for eryKR1 and tylKR1, tethering of the
diketide keto substrate, via thioester linkage to the
40-phosphopantetheinyl prosthetic group of an acyl car-
rier protein, is not a requirement for stereospecific and
stereoselective reduction, nor is the context of the
PKS essential for the integrity of this stereochemical
outcome. If the tylosin PKS resembles DEBS [13, 14]
and recruits only (2S)-methylmalonyl-CoA as extension
units, and not the (2R) isomer, and if (as with DEBS
[18]) the initial carbon-carbon bond formation on the ke-
tosynthase proceeds with retention of configuration at
C-2, then the initially formed diketide would be the
(2R) isomer. Unlike the DEBS, the tylosin PKS therefore
has no need of an epimerization step to convert this
isomer into the (2S) isomer before ketoreduction can
occur. Because of this, we initially considered it possible
that the tylosin KR1 might not in its usual context be
confronted with the (2S) isomer, and that as an isolated
domain, it might not be able to discriminate effectively
against this substrate. The results in Table 3 do not sup-
port that view, since only 1% of the products arise from
reduction of the (2S) isomer.Table 3. Percentage of Each 2-Methyl-3-Hydroxy Stereoisomer Produced by Reduction of (2R, S)-2-Methyl-3-Oxopentanoic Acid by PKS
Ketoreductases
Percentage of Each Stereoisomera
Ketoreductase
GST-eryKR1 100 0 0 0
GST-eryKR2 20 (6 3) 74 (64) 0 6 (6 1)
GST-eryKR5 2 (6 0.7) 74 (6 3) 0 24 (6 1)
GST-eryKR6 5 (6 2) 70 (6 4) 0 25 (6 2)
eryKR5 + eryKR6 (DEBS 3) 4 (6 1) 54 (6 3) 0 42 (6 2)
GST-tylKR1 1 (6 0.4) 0 99 (6 1) 0
a The stereoisomer predicted to be the unique product of each KR, based on its role in the PKS, is shown in bold type.
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tase eryKR1 Showing Two Alternative Binding
Modes of the Synthetic Substrate (2S)-2-
Methyl-3-Oxopentanoyl-NAC Thioester
(A and B) The orientation in (A) yields the (2S,
3R) diasteroisomer of the product alcohol,
while the orientation in (B) yields the (2S,
3S) diastereoisomer. The NADPH cofactor
is shown in red, and active site residues
Ser136 and Tyr149, which polarize the sub-
strate carbonyl group, are highlighted. For
further details, refer to Figure 3 and the text.
The derivation of the homology model will
be presented separately (A.B.-O. et al., sub-
mitted).In contrast, those KR domains that would not nor-
mally process diketide substrates gave mixtures of ste-
reoisomeric products in these assays. For example, the
multienzyme DEBS 3 (which houses both eryKR5 and
eryKR6 domains), which we purified as a recombinant
protein from extracts of E. coli as previously described
[27], gave only 42% of the expected (2R, 3S) product.
We previously reported that diketide ketoreduction on
this enzyme gave roughly equal amounts of all four
isomers [20], but our present reanalysis showed that,
under the conditions used here, the only other major
product was the (2S, 3S) isomer, in which the opposite
enantiomer is accepted but nevertheless reduced from
the correct face at C-3. Consistent with this, when the
individual eryKR5 and eryKR6 domains were assayed,
the same pattern was found, except that the expected
isomer formed only 25% of the total product mixture.
These data could be taken as evidence that the specific-
ity of these domains can be altered and heightened by
their incorporation into a multienzyme assembly line,
or by tethering the substrates to an appropriate ACP do-
main. The obvious caveat is that these enzymes might
also have shown full integrity of stereochemical out-
come had they been presented with substrates more
closely resembling their natural substrates.
The results obtained with ketoreduction by eryKR2
(Table 3) are even more important. Here, the predicted
(2R, 3S) product represents only 6% of the product
mixture, and, in this case, the ‘‘wrong’’ stereoisomer
not only serves as a substrate, but gives rise to signifi-
cant amounts of products arising by hydride delivery
from NADPH to either face at C-3. Taken together, these
data show once again that it cannot be assumed that an
unnatural substrate will always be correctly processed
by the KR domains in an engineered hybrid PKS [20].
The stereospecificity of eryKR2 is less evidently hard-
wired, although it still catalyzes reduction from the ‘‘cor-
rect’’ face of the keto group 80% of the time.
Two Alternative Binding Modes of Diketide
Substrates in the Active Sites of PKS
Ketoreductases
It has been previously shown that in KRs 1, 2, 5, and 6
the pro-S hydrogen is specifically delivered to the keto
substrate from the C-40 of NADPH [28, 29]. The KR do-
mains of modular PKSs have high sequence similarity
to each other, and to the KR domain of fatty acid syn-
thase, and homology modelling and site-directed muta-
genesis [15] has confirmed that they are members of thefamily of short-chain dehydrogenase/reductase (SDR)
enzymes [30], with an active site containing highly con-
served lysine, serine, and tyrosine residues (and possi-
bly also asparagine) [15]. We have independently
obtained a detailed homology model of both eryKR1
and eryKR2 (A.B.-O. et al., submitted) that shows that
eryKR1 and eryKR2 have exactly the same overall fold
and a highly similar active site geometry. In particular,
the positioning of the NADPH coenzyme and of critical
active site residues Ser136 and Tyr149 (numbering ac-
cording to [16]), which are likely to be involved in the po-
larization of the keto group [15], are predicted to be
essentially identical for KR1 and for KR2 (Figure 2).
Figure 3 summarizes how we propose the differ-
ent stereochemical outcomes of reduction by eryKR1,
eryKR2, and the other KRs studied arise: from two alter-
native binding modes of each enantiomeric diketide
substrate to the active site. Although confirmation of
this idea must await detailed structural studies on KR
domains with bound substrate, it accounts straightfor-
wardly for the observed range of behavior of the various
KRs. As the results in Table 3 show, a single enantiomer
in only one of the two binding modes may be exclusively
favored (eryKR1 and tylKR1). In the other cases studied,
when the correct enantiomer is bound, the reduction
does take place specifically from the predicted face
(eryKR2, eryKR5, and eryKR6). For these three enzymes,
however, the reduction of the ‘‘wrong’’ enantiomer is ki-
netically favored and, in the case of KR2, gives rise to
significant reduction even from the ‘‘wrong’’ face of
the keto group.
The idea of two alternative binding modes, and the
observation of product mixtures in our experiments,
leads to the prediction that the detailed arrangement
of relatively few amino acids in the respective active
sites of individual KRs might be a key determinant of
stereochemical outcome. It has already been reported
[15, 16] that certain amino acid residues are character-
istic of natural modular PKS KRs that reduce from one
or the other face of a ketoacylthioester substrate. In par-
ticular, Caffrey [16] has carefully documented two amino
acid motifs, which he terms A- and B-side selective,
whose respective absence or presence are hallmarks
of these two groups of enzymes (Figure 4). As will be
discussed in detail separately (A.B.-O. et al., submitted),
the residues of the Caffrey motifs both lie in the KR
active site predicted from homology modeling (Fig-
ure 2). Recently, two research groups [31, 32] have in-
dependently determined crystal structures for the
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Methyl-3-Oxopentanoic Acid NAC Thioest-
ers in the Active Site of PKS Ketoreductases
The relative positions of the NADPH cofactor
and the active site catalytic residues re-
quired to polarize the keto group (Ser136
and Tyr149) remain fixed, and, therefore,
the orientation of the substrate within the
active site determines the observed direc-
tion of ketoreduction. eryKR1 yields only the
(2S, 3R) product, and tylKR1 almost ex-
clusively yields the (2R, 3R) product. In
contrast, eryKR2, eryKR5, and eryKR6 give
mixtures of products.actinorhodin KR, which specifically reduces the C-9
keto group during the biosynthesis of this aromatic pol-
yketide. These structures confirm that the Caffrey mo-
tifs are predicted to lie within the KR active site, but
these sequence motifs are not conserved in aromatic
KRs [32], and no clear prediction could be made from in-spection of the crystal structure as to which stereo-
isomer of the alcohol would be produced [32]. The
respective roles of individual amino acid residues
in controlling stereospecificity and stereoselectivity
therefore remain to be determined, for both aromatic
and modular PKS KRs. It remains an attractive ideaFigure 4. Amino Acid Motifs, which Are Puta-
tively Involved in the Control of Stereochem-
istry by KR Domains from the Erythromycin
and Tylosin PKSs
Amino acid motifs have been identified by
Caffrey [16].
(A) The strongest indicator for B-type KR do-
mains is an LDD motif in the region between
amino acids 88 and 103, which is absent from
A-type KR domains. Additional amino acids in
the 134–149 region, specifically P144 and
N148, which indicate B-type KRs, and W141
in A-type domains, support this assignment.
(B) Sequence alignment of KR domains from
the erythromycin and tylosin PKSs. The ac-
tive site motifs, where present, are indicated
in bold (residues are numbered according to
[16]). Note that tylKR1 has W141 although it
is a B-type KR.
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the active site, and especially the residues comprising
the Caffrey motifs, might trigger a switch of stereo-
chemical outcome in modular PKS KRs. There is clear
precedent for this in the recent demonstration that the
stereoselectivity of tropinone reductases that reduce,
respectively, (+)- and (2)-tropinone can be switched
by site-directed mutagenesis [33]. These enzymes are
also members of the SDR family of NAD(P)H-linked ke-
toreductases, and their active site geometry has been
shown to be closely related to that of the actinorhodin
KR [31]. Now that the modular PKS KR domains can
be conveniently studied as individual recombinant
enzymes, this idea can be readily tested by using exper-
imental approaches based on both site-directed muta-
genesis and molecular evolution.
Significance
Numerous strategies have been successfully devel-
oped to engineer modular PKSs, and also downstream
post-PKS enzymes, to produce chemically altered poly-
ketide products for use in drug discovery. In contrast,
attempts to alter the configuration at specific stereo-
centers have been hampered by our limited under-
standing of the fundamental mechanisms by which
PKSs exert stereocontrol over polyketide assembly.
We have shown that individual KR domains can be ex-
pressed as enzymatically active enzymes in E. coli,
separate from other PKS activities. The KR domains
show a range of kinetic and stereochemical behavior
against synthetic diketide thioester substrates. KR do-
mains that normally act on diketide substrates showed
essentially complete stereocontrol, demonstrating
that this is a property intrinsic to the KR. In contrast,
the other KR domains discriminated poorly between
stereoisomeric substrates and reduced certain sub-
strates from both faces of the keto group. These re-
sults show that KR stereocontrol is intrinsic, but also
delicately balanced, and so it cannot be assumed
that a KR in the context of a hybrid PKS will behave
faithfully. On the other hand, this even energetic bal-
ance may herald the possibility of engineering a switch
in the stereospecificity of a given KR domain, by tar-
geting key active site residues. This could lead to
more reliable and efficient engineering of polyketide
stereochemistry.
Experimental Procedures
Materials
Routine cloning and transformation procedures were as previously
described for E. coli [34]. Electrocompetent cells of the E. coli
DH10B strain were made as described previously [35]. All antibiotics
were bought from Sigma. PCR reactions were performed on a pro-
grammable Robo Cycler Gradient 96 (Stratagene). Automated DNA
sequencing was carried out on double-stranded DNA templates by
using an automated ABI Prism 3700 DNA Analyzer (Applied Biosys-
tems). LB medium contained 10 g tryptone (Duchefa), 5 g yeast ex-
tract (Duchefa), and 10 g NaCl in 1 L MQ water.
Cloning Procedures
The DNA fragment corresponding to eryKR1 (accession num-
ber Q03131) was amplified by PCR by using Pfu polymerase
(Stratagene) and oligonucleotides 50-GTCCACCGGATCCGACGAG
GTTTCCGCGCTGCG-30 and 50-GGGCAGGAATT CTCACGCGCCCACCCGCGGTTCGGC-30 as primers and by using a pCJR24-based
plasmid containing the gene for DEBS 1-TE as the template [36].
The DNA fragment corresponding to eryKR2 was amplified as de-
scribed above, but by using oligonucleotides 50-GCACCACCGGA
TCCGACGAGCTCGACGGCTGGTTCTAC-30 and 50-GCACGCGGCA
GGAATTCTCACCGGTCGCGCAGGCTCTC-30 as primers. For tylKR1
(accession number U78289), oligonucleotides 50-ACGACCGGATCC
AGCCCCACCGATGCCTGGCGCTAC-30 and 50-TCAGCATGAATTC
TCACCGCGCCAGCTCGGGCGCGC-30 were used as primers, and
cosmid pTB2, containing the PKS genes for the biosynthesis of ty-
losin, was used as the template. eryKR5 and eryKR6 were PCR am-
plified from a plasmid (pIB023, I.U. Bo¨hm, personal communication)
containing the three DEBS genes by using primers 50-GGACGGAT
CCGACGACTGGCGCTA-30 and 50-GCAGGAATTCTCAGAGCCGCT
GGGCGAGCGCCGGGCCCTCCT-30 for eryKR5, and 3-CGACGGA
TCCGCCGACAGCCGCTACCGCGTCGACTGG-50 and 3-ACTCGAA
TTCTCACGTCATCTCCCGCGCCGGGGCCGCCT-50 for eryKR6. All
constructs were checked by DNA sequencing, and the resulting
DNA fragments were cloned into pGEX4T-3 (Amersham) by diges-
tion with BamHI and EcoRI. With the exception of tylKR1, all of the
KRs were subcloned into pGEX-6P-1 (Amersham) by digestion
with BamHI and EcoRI.
Protein Expression
One liter of culture in LB medium of E. coli-BL21-CodonPlus-RP
(Stratagene) harboring the recombinant plasmids was grown at
30ºC to an OD600 of 0.4, under carbenicillin (50 mg/ml) and chloram-
phenicol (34 mg/ml) selection. The cultures were cooled to 22ºC, and
upon reaching an OD600 of 0.6, were induced with 0.1 mM IPTG
(Melford Laboratories). After growth for an additional 16 hr, cells
were collected by centrifugation, and cell pellets were stored at
220ºC.
Protein Purification
Typically, frozen cell pellets were thawed and resuspended in lysis
buffer (50 mM NaH2PO4 [pH 8.2], 150 mM NaCl, 10% glycerol) con-
taining 1 tablet of protease inhibitors (Complete Roche), RNase (25
mg/L, Sigma), DNase (100 mg/L, Sigma), and lysozyme (1 mg/ml,
Sigma). The cell suspensions were incubated on ice for 40 min
and were disrupted by sonication (Misonix, Inc.), and the insoluble
material was collected by centrifugation. The resulting supernatant
was applied to a 50% suspension of glutathione-agarose beads
(Sigma), prepared according to the manufacturer’s instructions,
and incubated for 45 min at 4ºC. The beads were washed by resus-
pending in 10 volumes of lysis buffer and were eluted by incubating
in elution buffer (50 mM Tris-HCl [pH 8.0], 10 mM reduced glutathi-
one) for 30 min at 4ºC on a rotor. The elution step was repeated three
times, and the fractions were collected. Typical yields for all pro-
teins were 10213 mg/L of culture, as measured by the Bradford as-
say.
Cleavage of the GST fusion proteins was carried out by incubation
with human rhinovirus C protease (PreScission Protease, Amer-
sham) at a concentration of 20 U/mg GST-KR, in 50 mM Tris-HCl
buffer (pH 7.0), 150 mM NaCl, 1 mM EDTA, 1 mM DTT at 4ºC for
6–24 hr. Separation of the GST cleavage products was carried out
on an anion exchange column (MonoQ, Hi Prep Q FF [Amersham]).
The column was washed with two column volumes of HEPES buffer,
and the proteins were eluted by using a linear salt gradient (100–
1000 mM NaCl) over four column volumes.
Kinetic Assays
NADPH-linked assays were carried out at 30ºC in the chamber of
a Spectramax Plus microplate reader running Softmax Pr (Molecular
Devices) in 25 mM HEPES buffer (pH 7.5). The reactions were fol-
lowed by monitoring the change in absorbance at 340 nm at 30 s in-
tervals for 7 min in a UV transparent 96-well plate (Greiner Bio-One).
KR domains were used at 2–8 mM, and NADPH was used at 1.3 mM;
the substrates were dissolved in 3% DMSO, and their concentra-
tions varied between 0 and 50 mM (keeping the total amount of
DMSO constant). The total assay volume was 110 ml. The enzyme
was preincubated with NADPH for 20 min, the substrate was added,
and the reaction was mixed by shaking for 10 s before taking the
first reading, and for 3 s prior to each subsequent reading. All read-
ings were corrected for the change in absorbance at 340 nm in the
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least. The raw data were converted into a velocity (rate of consump-
tion of NADPH) for each concentration, and then the velocities were
plotted against substrate concentration. The data were fitted to the
Michaelis-Menten steady-state equation by using KaleidaGraph
(Abelbeck Software).
Product Separation by Chiral HPLC
Reduction of NAC-diketide substrate was carried out in a total vol-
ume of 200 ml containing 10 mM NADPH, 15 mM NAC-diketide, 400
mM NaH2PO4 (pH 7.5), and 1 mM KR enzymes. Reactions were incu-
bated at 22ºC for 16 hr and extracted with 3 ml ethyl acetate.
Extracts were evaporated and resuspended in 50 ml isopropanol.
The reaction products were separated by using a ChiralCel OC col-
umn (Daicel, 25 cm 3 4.6 mm) on an Agilent HPLC system at a flow
rate of 0.8 ml/min in an isocratic mobile phase of 93% isohexane/
7% ethanol at 40ºC for 2 hr. Control samples were run with each
batch of analyses to determine the retention times of the four dia-
stereoisomeric diketides, and, in a few cases, samples were spiked
with one of the standards.
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